IRadimed
Market Cap
US$262.4m
Last Updated
2019/10/20 00:38 UTC
Data Sources
Company Financials +
Executive Summary
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally.
Snowflake
Fundamentals
Flawless balance sheet with high growth potential.
Similar Companies
Share Price & News
How has IRadimed's share price performed over time and what events caused price changes?
Latest Share Price and Events
Market Performance
7 Day Return
6.5%
IRMD
1.9%
US Medical Equipment
0.4%
US Market
1 Year Return
-11.1%
IRMD
15.6%
US Medical Equipment
6.9%
US Market
Return vs Industry: IRMD underperformed the US Medical Equipment industry which returned 15.6% over the past year.
Return vs Market: IRMD underperformed the US Market which returned 6.9% over the past year.
Shareholder returns
| IRMD | Industry | Market | |
|---|---|---|---|
| 7 Day | 6.5% | 1.9% | 0.4% |
| 30 Day | 2.9% | -1.7% | -1.1% |
| 90 Day | 25.5% | -0.03% | -0.5% |
| 1 Year | -11.1%-11.1% | 16.5%15.6% | 9.3%6.9% |
| 3 Year | 134.3%134.3% | 72.1%66.9% | 45.8%36.4% |
| 5 Year | 220.1%220.1% | 125.8%100.8% | 62.9%45.1% |
Price Volatility Vs. Market
How volatile is IRadimed's share price compared to the market and industry in the last 5 years?
Simply Wall St News
4 days ago | Simply Wall St
Should You Be Impressed By IRadimed Corporation's (NASDAQ:IRMD) ROE?2 weeks ago | Simply Wall St
These Factors Make IRadimed Corporation (NASDAQ:IRMD) An Interesting Investment4 weeks ago | Simply Wall St
Does IRadimed Corporation (NASDAQ:IRMD) Have A Particularly Volatile Share Price?Valuation
Is IRadimed undervalued compared to its fair value and its price relative to the market?
31.55x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Undervalued: IRMD ($23.08) is trading above our estimate of fair value ($13.54)
Significantly Undervalued: IRMD is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: IRMD is good value based on its PE Ratio (31.5x) compared to the Medical Equipment industry average (42.2x).
PE vs Market: IRMD is poor value based on its PE Ratio (31.5x) compared to the US market (17.6x).
Price to Earnings Growth Ratio
Low PEG Ratio: IRMD is poor value based on its PEG Ratio (1.1x)
Price to Book Ratio
PB vs Industry: IRMD is overvalued based on its PB Ratio (5.5x) compared to the US Medical Equipment industry average (3.8x).
Next Steps
Future Growth
How is IRadimed forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?
29.4%
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: IRMD's forecast earnings growth (29.4% per year) is above the savings rate (2.7%).
Earnings vs Market: IRMD's earnings (29.4% per year) are forecast to grow faster than the US market (14.6% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: IRMD's revenue (22.9% per year) is forecast to grow faster than the US market (7.2% per year).
High Growth Revenue: IRMD's revenue (22.9% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
High Future ROE: Insufficient data to determine if IRMD's Return on Equity is forecast to be high in 3 years time
Next Steps
Past Performance
How has IRadimed performed over the past 5 years?
6.5%
Historical annual earnings growth
Earnings and Revenue History
Past Earnings Growth Analysis
Earnings Trend: IRMD's earnings have grown by 6.5% per year over the past 5 years.
Accelerating Growth: IRMD's earnings growth over the past year (212.6%) exceeds its 5-year average (6.5% per year).
Earnings vs Industry: IRMD earnings growth over the past year (212.6%) exceeded the Medical Equipment industry 28.2%.
Return on Equity
High ROE: IRMD's Return on Equity (17.1%) is considered low.
Return on Assets
ROA vs Industry: IRMD has a higher Return on Assets than the Medical Equipment industry average last year.
Return on Capital Employed
ROCE Improving: IRMD's Return on Capital Employed has declined over the past 3 years.
Next Steps
Financial Health
How is IRadimed's financial position?
Financial Position Analysis
Short Term Liabilities: IRMD's short term assets ($50.0M) exceeds its short term liabilities ($4.9M)
Long Term Liabilities: IRMD's short term assets (50.0M) exceeds its long term liabilities (4.8M)
Debt to Equity History and Analysis
Debt Level: IRMD is debt free.
Reducing Debt: IRMD had no debt 5 years ago.
Debt Coverage: IRMD has no debt, therefore it does not need to be covered by operating cash flow.
Interest Coverage: IRMD has no debt, therefore coverage of interest payments is not a concern.
Balance Sheet
Inventory Level: IRMD has a low level of unsold assets or inventory.
Debt Coverage by Assets: Insufficient data to determine if IRMD's debt is covered by short term assets.
Next Steps
Dividend
What is IRadimed's current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Current dividend yield vs market & industry
Stability and Growth of Payments
Notable Dividend: Unable to evaluate IRMD's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.
High Dividend: Unable to evaluate IRMD's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.
Stable Dividend: Insufficient data to determine if IRMD's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if IRMD's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of IRMD's dividend in 3 years as they are not forecast to pay a notable one for the US market.
Next Steps
Management
What is the CEO of IRadimed's salary, the management and board of directors tenure and is there insider trading?
6.8yrs
Average management tenure
CEO
Leslie McDonnell (46yo)
0.2yrs
Tenure
Ms. Leslie L. McDonnell has been Vice President and General Manager of Newborn Care Business Unit at Natus Medical Incorporated since joining it on February 12, 2018. Ms. McDonnell served as Global Busines ...
Management Age and Tenure
6.8yrs
Average Tenure
62yo
Average Age
Experienced Management: IRMD's management team is seasoned and experienced (6.8 years average tenure).
Board Age and Tenure
3.3yrs
Average Tenure
66yo
Average Age
Experienced Board: IRMD's board of directors are considered experienced (3.3 years average tenure).
Insider Trading
Insider Buying: IRMD insiders have only sold shares in the past 3 months.
Recent Insider Transactions
| Entity | Individual |
| Role | Controller Controller |
| Shares | 25,000 |
| Max Price | US$23.53 |
| Entity | Individual |
| Shares | 1,418 |
| Max Price | US$26.07 |
Ownership Breakdown
Management Team
Roger Susi (66yo)
Founder
- Tenure: 3.3yrs
- Compensation: US$494.58k
Brent Johnson (60yo)
Executive Vice President of Worldwide Sales & Marketing
- Tenure: 7.8yrs
- Compensation: US$453.91k
Chris Scott (49yo)
CFO & Secretary
- Tenure: 5.8yrs
- Compensation: US$508.45k
Louis Waldman (64yo)
Controller
- Tenure: 14.8yrs
John McCreery (64yo)
Chief Operating Officer
- Tenure: 2.5yrs
- Compensation: US$436.56k
Leslie McDonnell (46yo)
President
- Tenure: 0.2yrs
Board Members
Jim Hawkins (63yo)
Independent Director
- Tenure: 0.3yrs
- Compensation: US$35.50k
Roger Susi (66yo)
Founder
- Tenure: 3.3yrs
- Compensation: US$494.58k
Anthony Vuoto (68yo)
Independent Director
- Tenure: 3.6yrs
- Compensation: US$152.50k
Monty Allen (66yo)
Independent Director
- Tenure: 5.8yrs
- Compensation: US$155.00k
Leslie McDonnell (46yo)
President
- Tenure: 0.2yrs
Company Information
IRadimed Corporation's company bio, employee growth, exchange listings and data sources
Key Information
- Name: IRadimed Corporation
- Ticker: IRMD
- Exchange: NasdaqCM
- Founded: 1992
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: US$262.408m
- Shares outstanding: 11.37m
- Website: https://www.iradimed.com
Number of Employees
Location
- IRadimed Corporation
- 1025 Willa Springs Drive
- Winter Springs
- Florida
- 32708
- United States
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| IRMD | NasdaqCM (Nasdaq Capital Market) | Yes | Common Shares | US | USD | Jul 2014 |
| 46K | BST (Boerse-Stuttgart) | Yes | Common Shares | DE | EUR | Jul 2014 |
| 46K | DB (Deutsche Boerse AG) | Yes | Common Shares | DE | EUR | Jul 2014 |
Biography
IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationa ...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2019/10/20 00:38 |
| End of Day Share Price | 2019/10/18 00:00 |
| Earnings | 2019/06/30 |
| Annual Earnings | 2018/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.